Perelman School of Medicine/ Faculty Search/ Priti Lal

Priti Lal, MD

Assistant Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania

Department: Pathology and Laboratory Medicine

Contact information

Department of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania
6 Founders Pavilion
3400 Spruce Street
Philadelphia, PA 19104-4283

Office: 2156626505

Email:
priti.lal@uphs.upenn.edu

Education:
B.S. (Genetics)
Delhi University, Delhi, India, 1984.
MD
Maulana Azad Medical College, Delhi, India, 1990.

Permanent link

Perelman School of Medicine > Faculty > Search

Description of Research Expertise

Application of high through-put technology to gain insights into the biology of human cancers, with special interest in GU cancers.

Description of Clinical Expertise

GU Pathology. Cardiovascular and renal transplantation pathology.
Breast Pathology

Selected Publications

Lal Priti, Salazar PA, Ladanyi M, Chen B. : Impact of polysomy 17 on Her-2/neu immunohistochemistry in breast carcinomas without her-2/neu gene amplification. Journal of Molecular Diagnostics 5(3), Aug 2003.

Holzbeierlein, J, Lal, Priti, LaTulippe E, Smith A, Satagopan J, Zhang L,Ryan C, Smith S, Scher H, Scardino P, Reuter VE, Gerald WL.: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and multiple complimentary mechanisms of therapy resistance. American Journal of Pathology, 164 (1): 217-227, 2004.

Priti Lal, Donaton M.C, Giri D, Chen B, Gerald WL.: Molecular diagnosis of Breast Cancer Therapeutic Biomarkers Using Oligonucleotide Arrays. Modern Pathology, 18 (1): 39A, 2005.

Lal P, Tan LK, Chen B: Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3,655 invasive breast carcinomas. Am J Clin Pathol 123(4): 541-6, 2005.

Gordan JD, Lal P, Dondeti VR, Letrero R, Parekh KN, Oquendo CE, Greenberg RA, Flaherty KT, Rathmell WK, Keith B, Simon MC, Nathanson KL. : HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell 14(6): 435-46, December 2008.

Charles J Ryan, Alex Smith, Priti Lal, Jaya Satagopan, Victor Reuter, Peter Scardino, William Gerald, Howard I Scher : Persistent prostate-specific antigen expression after neoadjuvant androgen depletion: An early predictor of relapse or incomplete androgen suppression. Urology. 68(4): 834-9 October 2006

Barroeta JE M.D.,Baloch ZW, M.D. PhD*., P Lal, M.D., T. L. Pasha, B.S., P.J. Zhang, M.D. PhD, V.A. LiVolsi M.D: Diagnostic Value of Differential Expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in Benign and Malignant Follicular-Derived Lesions of the Thyroid: An Immunohistochemical Tissue Microarray Analysis. Endocrine Pathology 17(3): 225-34, Fall 2006.

Z Bing, TL Pasha, Priti Lal, JE Tomaszewski : NANOG, a Sensitive and Specific Marker for Seminoma and Embryonal Carcinoma in Retroperitoneal Lymph Node Dissection Specimens. Modern Pathology. (1), 2006.

Doane, A S. Danso, M. Lal, P. Donaton, M. Zhang, L. Hudis, C. Gerald, W L. : An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Breast Cancer Res Treat 94: S18, 2005.

Frederick, William; Wang, Huiyi; Zheng, Yomgmu; Boyer,Jean; Schullery, Dan; Aqui,Nicole; Lal, Priti; Tomaszewski, John; McGarvey, Terry; Malkowics, S: Elevated TERE1 protein induces cytokine expression in J82 bladder cancer and human immune cells Journal of Urology 179(4), 2008.

Bhargava R, Lal P, Chen B: HER-2/neu and topoisomerase IIa gene amplification and protein expression in invasive breast carcinomas: chromogenic in situ hybridization and immunohistochemical analyses. Am J Clin Pathol 123(6): 889-95, 2005

Doane, AS; Danso, M; Lal, P; Gerald W: Distinct PIK3CA mutation profiles in estrogen receptor (ER) negative breast cancer subset. Journal of Clinical Oncology. 24(18): 540, 2006.